Ovarian clear cell carcinoma (oCCC) is a distinctive subtype of ovarian carcinoma, with peculiar genetic and environmental risk factors, precursor lesions, molecular events during oncogenesis, patterns of spread, and response to treatment. Because of low response to chemotherapy and poor prognosis in advanced stages, there is growing interest in investigating the molecular pathways involved in oCCC development, in order to individualize novel/molecular targeted therapies. Until now, the main molecular genetic changes associated with oCCC remain to be identified, and, although several molecular changes have been reported in clear cell tumors, most studies have analyzed a limited number of cases; therefore, the true prevalence of those change...
Ovarian carcinomas are heterogenous group of diseases comprising various histotypes. Ovarian carcino...
The recent advances in the understanding of the pathogenesis of ovarian cancer have been helpful in ...
Ovarian cancer treatment presently does not reflect molecular differences in histologic subtype. Ova...
PurposeTo identify molecular subclasses of clear cell ovarian carcinoma (CCOC) and assess their impa...
Ovarian clear-cell carcinomas (OCCC) accounts for 10% of the epithelial ovarian cancers, a cancer ty...
Clear cell carcinoma of the ovary is a rare and distinct histotype of epithelial ovarian carcinomas....
Objective: Ovarian clear cell carcinomas (OCCCs) constitute a rare ovarian cancer subtype with disti...
Introduction: Ovarian clear cell carcinoma (OCCC) is a less common subtype accounting for approximat...
Ovarian clear cell carcinoma (OCCC) accounts for a small but significant proportion of all ovarian c...
Ovarian carcinomas represent a heterogeneous group of neoplasms consisting of separate entities with...
Abstract Background Ovarian clear cell carcinoma is a distinct histologic subtype with grave surviva...
Ovarian cancer is the leading cause of death among women with gynecologic malignancies. Epithelial t...
Objectives. Ovarian cancer remains a major health problem for women. Although there is considerable ...
Ovarian clear cell carcinomas (OCCC) are rare aggressive, chemo-resistant tumours comprising approxi...
(Print Edition)Ovarian cancer is the most lethal gynaecological malignancy and it most commonly occu...
Ovarian carcinomas are heterogenous group of diseases comprising various histotypes. Ovarian carcino...
The recent advances in the understanding of the pathogenesis of ovarian cancer have been helpful in ...
Ovarian cancer treatment presently does not reflect molecular differences in histologic subtype. Ova...
PurposeTo identify molecular subclasses of clear cell ovarian carcinoma (CCOC) and assess their impa...
Ovarian clear-cell carcinomas (OCCC) accounts for 10% of the epithelial ovarian cancers, a cancer ty...
Clear cell carcinoma of the ovary is a rare and distinct histotype of epithelial ovarian carcinomas....
Objective: Ovarian clear cell carcinomas (OCCCs) constitute a rare ovarian cancer subtype with disti...
Introduction: Ovarian clear cell carcinoma (OCCC) is a less common subtype accounting for approximat...
Ovarian clear cell carcinoma (OCCC) accounts for a small but significant proportion of all ovarian c...
Ovarian carcinomas represent a heterogeneous group of neoplasms consisting of separate entities with...
Abstract Background Ovarian clear cell carcinoma is a distinct histologic subtype with grave surviva...
Ovarian cancer is the leading cause of death among women with gynecologic malignancies. Epithelial t...
Objectives. Ovarian cancer remains a major health problem for women. Although there is considerable ...
Ovarian clear cell carcinomas (OCCC) are rare aggressive, chemo-resistant tumours comprising approxi...
(Print Edition)Ovarian cancer is the most lethal gynaecological malignancy and it most commonly occu...
Ovarian carcinomas are heterogenous group of diseases comprising various histotypes. Ovarian carcino...
The recent advances in the understanding of the pathogenesis of ovarian cancer have been helpful in ...
Ovarian cancer treatment presently does not reflect molecular differences in histologic subtype. Ova...